Close Menu

NEW YORK (GenomeWeb) – Genomic Health reported today that its fourth quarter revenues rose 22 percent year over year, beating the consensus Wall Street estimate of $101.5 million.

For the three months ended Dec. 31, 2018, the company's total revenues were $104.6 million compared to $87.5 million reported in Q4 2017 and $85.7 million adjusted to a subsequent switch to the ASC-606 accounting standard.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.